Nanochemistry offering innovative solutions for drug development, delivery, and diagnostics. At the nanoscale, materials exhibit unique properties that can be harnessed to enhance the therapeutic efficacy of pharmaceutical compounds. Nanostructured drug delivery systems, such as liposomes, micelles, and nanoparticles, enable targeted and controlled release of drugs, optimizing their bioavailability and minimizing side effects. Additionally, nanochemistry facilitates the design of nanoscale drug carriers that can overcome biological barriers, improving drug penetration and cellular uptake.
The application of nanotechnology in pharmaceuticals extends beyond drug delivery, encompassing diagnostic tools and imaging agents that enhance the precision and sensitivity of disease detection. Moreover, nanochemistry enables the synthesis of nanoscale materials for theranostic purposes, combining therapeutic and diagnostic functionalities in a single platform. The interdisciplinary nature of nanochemistry in the pharmaceutical field underscores its potential to revolutionize drug development and patient care, offering tailored solutions for complex medical challenges.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico